Hello, Fool! | Login | Signup | My Fool
Jul 24, 2008 2:20 AM ET | Site Changes | Help
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
View All Commentary (AZN)
Recs
omoplata (90.90) Submitted: 4/10/07 12:45 PM : Start Price: $51.66 AZN Score: 0.51
Stock is undervalued.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK